Clark GM - Search Results

1

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.

Elledge RM, Clark GM, Chamness GC, Osborne CK. Elledge RM, et al. Among authors: clark gm. J Natl Cancer Inst. 1994 May 4;86(9):705-12. doi: 10.1093/jnci/86.9.705. J Natl Cancer Inst. 1994. PMID: 7908990

2

Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome.

Arpino G, Clark GM, Mohsin S, Bardou VJ, Elledge RM. Arpino G, et al. Among authors: clark gm. Cancer. 2002 Apr 15;94(8):2119-27. doi: 10.1002/cncr.10455. Cancer. 2002. PMID: 12001107 Free article. Review.

3

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.

Chang J, Clark GM, Allred DC, Mohsin S, Chamness G, Elledge RM. Chang J, et al. Among authors: clark gm. Cancer. 2003 Feb 1;97(3):545-53. doi: 10.1002/cncr.11083. Cancer. 2003. PMID: 12548595 Free article.

4

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer.

Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SA, Wong J, Allred DC, Clark GM, Schiff R. Osborne CK, et al. Among authors: clark gm. J Natl Cancer Inst. 2003 Mar 5;95(5):353-61. doi: 10.1093/jnci/95.5.353. J Natl Cancer Inst. 2003. PMID: 12618500

5

Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer.

Elledge RM, Gray R, Mansour E, Yu Y, Clark GM, Ravdin P, Osborne CK, Gilchrist K, Davidson NE, Robert N, et al. Elledge RM, et al. Among authors: clark gm. J Natl Cancer Inst. 1995 Aug 16;87(16):1254-6. doi: 10.1093/jnci/87.16.1254. J Natl Cancer Inst. 1995. PMID: 7563172 Clinical Trial. No abstract available.

6

The p53 tumor-suppressor gene in human breast cancer.

Allred DC, Elledge R, Clark GM, Fuqua SA. Allred DC, et al. Among authors: clark gm. Cancer Treat Res. 1994;71:63-77. doi: 10.1007/978-1-4615-2592-9_4. Cancer Treat Res. 1994. PMID: 7946959 Review. No abstract available.

7

p53 protein accumulation detected by five different antibodies: relationship to prognosis and heat shock protein 70 in breast cancer.

Elledge RM, Clark GM, Fuqua SA, Yu YY, Allred DC. Elledge RM, et al. Among authors: clark gm. Cancer Res. 1994 Jul 15;54(14):3752-7. Cancer Res. 1994. PMID: 8033095

8

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: clark gm. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

9

Prognostic significance of p53 gene alterations in node-negative breast cancer.

Elledge RM, Fuqua SA, Clark GM, Pujol P, Allred DC, McGuire WL. Elledge RM, et al. Among authors: clark gm. Breast Cancer Res Treat. 1993;26(3):225-35. doi: 10.1007/BF00665800. Breast Cancer Res Treat. 1993. PMID: 8251647

10

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Encarnación CA, Ciocca DR, McGuire WL, Clark GM, Fuqua SA, Osborne CK. Encarnación CA, et al. Among authors: clark gm. Breast Cancer Res Treat. 1993;26(3):237-46. doi: 10.1007/BF00665801. Breast Cancer Res Treat. 1993. PMID: 8251648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

766 results

Search Page